Hypertension · 2013 · 42 citations · 55 references
Life SciencesObstetricsPhysiologyCell SignalingMaternal-fetal MedicineSignal TransductionHypertensive DisordersMaternal-fetal PhysiologyPlacental PhysiologyPregnancyPregnancy PhysiologyPregnancy-induced HypertensionPlacental ApoptosisPlacental Dysfunction In PreeclampsiaPlacental IschemiaPlacental PathophysiologyPreeclampsia PathophysiologyPregnancy-related HypertensionReceptorsUteroplacental Ischemia
Preeclampsia, a prevalent hypertensive disorder of pregnancy, is believed to be secondary to uteroplacental ischemia. Accumulating evidence indicates that hypoxia-independent mediators, including inflammatory cytokines and growth factors, are associated with preeclampsia, but it is unclear whether these signals directly contribute to placental damage and disease development in vivo. We report that LIGHT, a novel tumor necrosis factor superfamily member, is significantly elevated in the circulation and placentas of preeclamptic women compared with normotensive pregnant women. Injection of LIGHT into pregnant mice induced placental apoptosis, small fetuses, and key features of preeclampsia, hypertension and proteinuria. Mechanistically, using neutralizing antibodies specific for LIGHT receptors, we found that LIGHT receptors herpes virus entry mediator and lymphotoxin β receptor are required for LIGHT-induced placental impairment, small fetuses, and preeclampsia features in pregnant mice. Accordingly, we further revealed that LIGHT functions through these 2 receptors to induce secretion of soluble fms-like tyrosine kinase-1 and endothelin-1, 2 well-accepted pathogenic factors in preeclampsia, and thereby plays an important role in hypertension and proteinuria in pregnant mice. Lastly, we extended our animal findings to human studies and demonstrated that activation of LIGHT receptors resulted in increased apoptosis and elevation of soluble fms-like tyrosine kinase-1 secretion in human placental villous explants. Overall, our human and mouse studies show that LIGHT signaling is a previously unrecognized pathway responsible for placental apoptosis, elevated secretion of vasoactive factors, and subsequent maternal features of preeclampsia, and reveal new therapeutic opportunities for the management of the disease.
55
Sharon E. Maynard, Jiang-Yong Min, Jaime R. Merchan et al. · Journal of Clinical Investigation · 2003 · 4K citations · Full text
Circulating Angiogenic Factors and the Risk of Preeclampsia
Richard J. Levine, Cong Qian, Lucinda J. England et al. · New England Journal of Medicine · 2004 · 3.6K citations · Full text
Circulating angiogenic factors and the risk of preeclampsia*
Obstetrics and Gynecology · 2004 · 2.6K citations
Medicine, Gynecology, Obstetrics +14
Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha, Mourad Toporsian, Chun Sing Lam et al. · Nature Medicine · 2006 · 1.8K citations
In utero programming of chronic disease
D.J.P. BARKER · Clinical Science · 1998 · 1.4K citations